Oncology

Latest News

LASZLO-stock.adobe.com
FDA Issues CRL for Odronextamab for Lymphoma Indications

March 25th 2024

FDA officials indicated that the confirmatory trial for odronextamab for patients with follicular lymphoma and diffuse large B-cell lymphoma should be under way before resubmission.

FDA Grants Full Approval to Elahere
FDA Grants Full Approval to Elahere

March 25th 2024

FDA Approves Iclusig for New Patients with Aggressive Leukemia
FDA Approves Iclusig for New Patients with Aggressive Leukemia

March 19th 2024

FDA Sets Action Date for Resubmitted Lymphir in Rare Skin Cancer
FDA Sets Action Date for Resubmitted Lymphir in Rare Skin Cancer

March 18th 2024

Dr_Microbe-stock.adobe.com
FDA Approves Tevimbra for Esophageal Cancer

March 15th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.